lantus
sanofi-aventis deutschland gmbh - insulin glargine - cukura diabēts - cukura diabēts - cukura diabēta ārstēšana pieaugušajiem, pusaudžiem un bērniem no 2 gadu vecuma.
lusduna
merck sharp & dohme b.v. - insulin glargine - cukura diabēts - cukura diabēts - cukura diabēta ārstēšana pieaugušajiem, pusaudžiem un bērniem no 2 gadu vecuma.
toujeo (previously optisulin)
sanofi-aventis deutschland gmbh - insulin glargine - cukura diabēts - cukura diabēts - Ārstēšana ar cukura diabētu pieaugušajiem, pusaudžiem un bērniem vecumā no 6 gadiem.
suliqua
sanofi winthrop industrie - insulīna glargine, lixisenatide - cukura diabēts, 2. tips - cukura diabēts - suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sglt-2 inhibitors.
co-amlessa 4 mg/10 mg/1,25 mg tabletes
krka, d.d., novo mesto, slovenia - tert-butylamini perindoprilum, amlodipinum, indapamidum - tablete - 4 mg/10 mg/1,25 mg
co-amlessa 4 mg/5 mg/1,25 mg tabletes
krka, d.d., novo mesto, slovenia - tert-butylamini perindoprilum, amlodipinum, indapamidum - tablete - 4 mg/5 mg/1,25 mg
co-amlessa 8 mg/10 mg/2,5 mg tabletes
krka, d.d., novo mesto, slovenia - tert-butylamini perindoprilum, amlodipinum, indapamidum - tablete - 8 mg/10 mg/2,5 mg
co-amlessa 8 mg/5 mg/2,5 mg tabletes
krka, d.d., novo mesto, slovenia - tert-butylamini perindoprilum, amlodipinum, indapamidum - tablete - 8 mg/5 mg/2,5 mg
semglee
viatris limited - insulin glargine - cukura diabēts - cukura diabēts - cukura diabēta ārstēšana pieaugušajiem, pusaudžiem un bērniem no 2 gadu vecuma.
co-amlessa 2 mg/5 mg/0,625 mg tabletes
krka, d.d., novo mesto, slovenia - tert-butylamini perindoprilum, amlodipinum, indapamidum - tabletes - 2 mg/5 mg/0,625 mg